MED14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.951000E-01
Normal-vs-Stage2
7.378200E-01
Normal-vs-Stage3
1.467030E-01
Normal-vs-Stage4
6.246800E-01
Stage1-vs-Stage2
6.417000E-01
Stage1-vs-Stage3
3.648000E-02
Stage1-vs-Stage4
4.587000E-01
Stage2-vs-Stage3
9.264200E-02
Stage2-vs-Stage4
1.557620E-01
Stage3-vs-Stage4
1.144780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.745200E-01
Normal-vs-AfricanAmerican
9.410400E-01
Normal-vs-Asian
5.329600E-01
Caucasian-vs-AfricanAmerican
6.396000E-01
Caucasian-vs-Asian
4.599400E-01
AfricanAmerican-vs-Asian
4.560400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.750400E-01
Normal-vs-Female
8.248800E-01
Male-vs-Female
2.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.613200E-01
Normal-vs-Age(41-60Yrs)
9.224800E-01
Normal-vs-Age(61-80Yrs)
5.396000E-01
Normal-vs-Age(81-100Yrs)
3.044600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.824200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.717200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.918800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.338160E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.310000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.058000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.141400E-01
Normal-vs-Daily Drinker
5.644000E-01
Normal-vs-Weekly Drinker
7.080600E-01
Normal-vs-Occasional Drinker
7.568200E-01
Normal-vs-Social Drinker
9.753600E-01
Non Drinker-vs-Daily Drinker
9.789000E-01
Non Drinker-vs-Weekly Drinker
6.394800E-01
Non Drinker-vs-Occasional Drinker
4.226400E-01
Non Drinker-vs-Social Drinker
2.163200E-01
Daily Drinker-vs-Weekly Drinker
6.908600E-01
Daily Drinker-vs-Occasional Drinker
4.875200E-01
Daily Drinker-vs-Social Drinker
2.770200E-01
Weekly Drinker-vs-Occasional Drinker
8.210200E-01
Weekly Drinker-vs-Social Drinker
5.210000E-01
Occasional Drinker-vs-Social Drinker
6.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.590200E-01
Normal-vs-Grade 2
6.996400E-02
Normal-vs-Grade 3
5.185600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.225620E-01
Grade 1-vs-Grade 3
2.750200E-02
Grade 1-vs-Grade 4
2.590200E-01
Grade 2-vs-Grade 3
1.972610E-01
Grade 2-vs-Grade 4
6.996400E-02
Grade 3-vs-Grade 4
5.185600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.608200E-01
Normal-vs-NonDiabetic
6.256800E-01
Diabetic-vs-NonDiabetic
3.495800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.623800E-01
Normal-vs-NoPancreatitis
5.565200E-01
Pancreatitis-vs-NoPancreatitis
7.670100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.839800E-01
Normal-vs-N1
7.184600E-01
N0-vs-N1
7.886000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.824000E-01
Normal-vs-TP53-NonMutant
8.418800E-01
TP53-Mutant-vs-TP53-NonMutant
1.126980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
